S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PCSA Processa Pharmaceuticals Inc

0.60

-0.032 (-5.06%)

Feb 05 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Processa Pharmaceuticals Charts.

Processa Pharmaceuticals Inc News

Form 8-K - Current report
Thursday 30 January 2025 (6 days ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Thursday 30 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 29 January 2025 (1 week ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Monday 27 January 2025 (1 week ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Monday 27 January 2025 (1 week ago) • Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Thursday 16 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 20 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
Wednesday 30 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 30 October 2024 (3 months ago) • Edgar (US Regulatory)

More Processa Pharmaceuticals Inc News Articles

Adia Nutrition (PK)

Decentral Life (PK)

TransCode Therapeutics

MineralRite (PK)

RespireRx Pharmaceuticals (CE)

Virexit Technologies (PK)

Liquidmetal Technologies (QB)

Elite Pharmaceuticals (QB)

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions